Oskotec CEO Taeyoung Yoon Receives KSMC Innovation Award
Recognized for Achievements in First-in-Class Drug Development and Technology Transfer
OSKOTEC announced on September 30 that CEO Taeyoung Yoon will receive the “Innovation Award” from the Korean Society of Medicinal Chemistry (KSMC) on October 1. The awards ceremony will take place at the 2nd Regular KSMC Academic Conference, held in Cheongju, Osco.
The KSMC Innovation Award is presented to researchers in medicinal chemistry who have contributed to the development of the industry through technological innovation and product development in the field of new drug discovery. CEO Yoon was recognized for establishing the foundation for first-in-class innovative drug research and development in Korea and successfully translating these achievements into technology transfer deals.
Hot Picks Today
"Two Spend 500,000 Won in a Flash, Yet Wait Two Hours?" ... 'Dreamland' Shunned by Kids and Foreign Tourists
- The Era of Getting 200 Million Won After 30 Years Is Over... A Japanese Bank's "Perpetual Department Head" Who Just Clocked In Cries Out
- Spain Hit by Its Worst Tragedy... Lee Kangin, Moreno and Real Madrid Join Soccer World in Mourning
- They Said, “Make It Your Home for Life” - Then Suddenly Kicked 200 Passengers Off... What Happened to the Around-the-World Cruise?
- "130 Rice Bowls Sold Out in a Day"... 'Unfiltered Face' Adds 8 Million Won to Night Market Sales: China's Bungeunwoo
OSKOTEC has continued to deliver business results this year, including the technology export of Cevidoplenib to Agios, the signing of a global exclusive technology transfer option contract for Denpivontinib, and the technology transfer of ADEL-Y01 to Sanofi.
© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.